Axim Biotechnologies, Inc. (AXIM): Total Liabilities
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$11.78M
As of 2023-12-31
+6.5%
3-year compound annual growth
+7.6%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $11.78M | +30.3% | 2024-04-16, Balance as of period end |
| 2022-12-31 | $9.04M | +18.0% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $7.66M | -21.4% | 2023-04-17, Balance as of period end |
| 2020-12-31 | $9.75M | +15.3% | 2022-04-19, Balance as of period end |
| 2019-12-31 | $8.45M | +3.4% | 2021-04-26, Balance as of period end |
| 2018-12-31 | $8.17M | -3.6% | 2020-05-20, Balance as of period end |
| 2017-12-31 | $8.48M | +121.9% | 2019-04-08, Balance as of period end |
| 2016-12-31 | $3.82M | +29.2% | 2018-03-15, Balance as of period end |
| 2015-12-31 | $2.96M | +124.1% | 2017-09-14, Balance as of period end |
| 2014-12-31 | $1.32M | n/a | 2016-04-18, Balance as of period end |
| No annual figure between 2011-12-31 and 2014-12-31. | |||
| 2011-12-31 | $62.1K | n/a | 2012-05-01, Balance as of period end |
| 2010-12-31 | $0 | n/a | 2012-05-01, Balance as of period end |